Correction
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics acquired the Humibid trademark from Cornerstone BioPharma in February 2005, but not the Humibid line as reported in the Nov. 13 issue of "The Tan Sheet." The article incorrectly described Adams CEO Michael Valentino's comments as implying that forecast data indicate harsh weather this winter season...